IHS Chemical Week

EnviroTech :: Biotech

Bayer Acquires Biotech Company

10:48 AM MDT | September 22, 2008 | Chemical Week Editorial Staff

Bayer HealthCare says it has acquired biotechnology company Direvo Biotech (Cologne) for €210 million ($298 million). Direvo specializes in protein engineering and “strengthens the research competence in biologics of the pharmaceuticals division Bayer Schering Pharma,” Bayer HealthCare says. The deal is scheduled to close at the end of this month. Bayer HealthCare plans to integrate Direvo’s R&D personnel into Bayer Schering Pharma’s drug discovery organization. Separately, Bayer’s share price rose again last week on...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers

 

 

 













 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2012 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa